CytoDel successfully delivers neuronal antibody in animal models of botulism
Tha CytoDel, Inc. (“CytoDel” or “The Company”), a private corporate entity, today announced the publication of preclinical data on the Company’s flagship product, Cyto-111, in the peer-reviewed jou…
